MY106615A - Stabilized leukocyte-interferons. - Google Patents
Stabilized leukocyte-interferons.Info
- Publication number
- MY106615A MY106615A MYPI90001656A MYPI19901656A MY106615A MY 106615 A MY106615 A MY 106615A MY PI90001656 A MYPI90001656 A MY PI90001656A MY PI19901656 A MYPI19901656 A MY PI19901656A MY 106615 A MY106615 A MY 106615A
- Authority
- MY
- Malaysia
- Prior art keywords
- interferons
- leukocyte
- stabilized
- stabilized leukocyte
- disaccharides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/212—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
THE STABILIZATION OF HUMAN INTERFERON WITH DISACCHARIDES AND OPTIONALLY BILE ACIDS OR BILE ACID DERIVATIVES.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH351489 | 1989-09-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY106615A true MY106615A (en) | 1995-06-30 |
Family
ID=4257630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI90001656A MY106615A (en) | 1989-09-28 | 1990-09-26 | Stabilized leukocyte-interferons. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0420049B1 (en) |
| JP (1) | JPH03130232A (en) |
| KR (1) | KR910005886A (en) |
| CN (1) | CN1050503A (en) |
| AR (1) | AR244551A1 (en) |
| AT (1) | ATE92334T1 (en) |
| AU (1) | AU636653B2 (en) |
| CA (1) | CA2024046A1 (en) |
| CZ (1) | CZ277712B6 (en) |
| DD (1) | DD298054A5 (en) |
| DE (1) | DE59002183D1 (en) |
| FI (1) | FI904756A7 (en) |
| HU (1) | HU205555B (en) |
| IE (1) | IE903479A1 (en) |
| IL (1) | IL95769A0 (en) |
| IS (1) | IS3631A7 (en) |
| MC (1) | MC2149A1 (en) |
| MX (1) | MX22522A (en) |
| MY (1) | MY106615A (en) |
| NO (1) | NO904218L (en) |
| NZ (1) | NZ235153A (en) |
| PH (1) | PH27531A (en) |
| PT (1) | PT95454A (en) |
| RU (1) | RU2008017C1 (en) |
| YU (1) | YU184090A (en) |
| ZA (1) | ZA907579B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994028020A1 (en) * | 1993-05-18 | 1994-12-08 | Bukh Meditec A/S | A method for the preparation of interferons |
| DE69715883T2 (en) * | 1996-05-09 | 2003-07-31 | Feronpatent Ltd., Gibraltar | STABILIZATION OF INTERFERONES IN AQUEOUS SOLUTION BY RUBBER LAB |
| EP1007083A1 (en) * | 1997-05-09 | 2000-06-14 | Feronpatent Limited | Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets |
| WO1999048535A1 (en) * | 1998-03-26 | 1999-09-30 | Schering Corporation | Formulations for protection of peg-interferon alpha conjugates |
| US6180096B1 (en) | 1998-03-26 | 2001-01-30 | Schering Corporation | Formulations for protection of peg-interferon alpha conjugates |
| CN1175901C (en) * | 1999-12-06 | 2004-11-17 | 天津华立达生物工程有限公司 | Stable water solution of interferon |
| CA2576549C (en) | 2004-08-12 | 2011-01-18 | Schering Corporation | Stable pegylated interferon formulation |
| DE102004048379A1 (en) | 2004-10-01 | 2006-04-13 | "Stiftung Caesar" (Center Of Advanced European Studies And Research) | Spring element made of sputtered shape memory alloy |
| CU23432B6 (en) * | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | STABILIZED FORMULATIONS CONTAINING GAMMA AND ALFA INTERFERONS IN POTENTIAL PROPORTIONS |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5821691A (en) * | 1981-07-29 | 1983-02-08 | Mochida Pharmaceut Co Ltd | Purifying method of interferon |
| EP0080879B1 (en) * | 1981-11-28 | 1986-10-01 | Sunstar Kabushiki Kaisha | Pharmaceutical composition containing interferon in stable state |
| DE3467706D1 (en) * | 1983-04-28 | 1988-01-07 | Armour Pharma | Pharmaceutical preparation containing purified fibronectin |
| DE3484374D1 (en) * | 1983-08-04 | 1991-05-08 | Green Cross Corp | GAMMA INTERFERON COMPOSITION. |
| OA08269A (en) * | 1985-03-25 | 1987-10-30 | Schering Corp | Stable interferon-gamma-based compositions |
| US4816568A (en) * | 1986-05-16 | 1989-03-28 | International Minerals & Chemical Corp. | Stabilization of growth hormones |
-
1990
- 1990-08-27 CA CA002024046A patent/CA2024046A1/en not_active Abandoned
- 1990-09-03 NZ NZ235153A patent/NZ235153A/en unknown
- 1990-09-06 CZ CS904328A patent/CZ277712B6/en unknown
- 1990-09-20 EP EP90118132A patent/EP0420049B1/en not_active Expired - Lifetime
- 1990-09-20 DE DE9090118132T patent/DE59002183D1/en not_active Expired - Fee Related
- 1990-09-20 AT AT90118132T patent/ATE92334T1/en not_active IP Right Cessation
- 1990-09-21 AU AU63098/90A patent/AU636653B2/en not_active Expired - Fee Related
- 1990-09-21 ZA ZA907579A patent/ZA907579B/en unknown
- 1990-09-24 MX MX2252290A patent/MX22522A/en unknown
- 1990-09-24 MC MC902149A patent/MC2149A1/en unknown
- 1990-09-24 HU HU906021A patent/HU205555B/en not_active IP Right Cessation
- 1990-09-25 IL IL95769A patent/IL95769A0/en unknown
- 1990-09-26 PH PH41267A patent/PH27531A/en unknown
- 1990-09-26 MY MYPI90001656A patent/MY106615A/en unknown
- 1990-09-26 AR AR90317958A patent/AR244551A1/en active
- 1990-09-26 DD DD90344228A patent/DD298054A5/en not_active IP Right Cessation
- 1990-09-27 JP JP2258806A patent/JPH03130232A/en active Pending
- 1990-09-27 CN CN90108133A patent/CN1050503A/en active Pending
- 1990-09-27 FI FI904756A patent/FI904756A7/en not_active IP Right Cessation
- 1990-09-27 PT PT95454A patent/PT95454A/en not_active Application Discontinuation
- 1990-09-27 IE IE347990A patent/IE903479A1/en unknown
- 1990-09-27 IS IS3631A patent/IS3631A7/en unknown
- 1990-09-27 RU SU904831274A patent/RU2008017C1/en active
- 1990-09-27 NO NO90904218A patent/NO904218L/en unknown
- 1990-09-27 KR KR1019900015368A patent/KR910005886A/en not_active Withdrawn
- 1990-09-28 YU YU184090A patent/YU184090A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO904218D0 (en) | 1990-09-27 |
| PH27531A (en) | 1993-08-18 |
| PT95454A (en) | 1991-05-22 |
| CS432890A3 (en) | 1992-12-16 |
| MX22522A (en) | 1993-10-01 |
| EP0420049A1 (en) | 1991-04-03 |
| AU636653B2 (en) | 1993-05-06 |
| DD298054A5 (en) | 1992-02-06 |
| CA2024046A1 (en) | 1991-03-29 |
| RU2008017C1 (en) | 1994-02-28 |
| HU906021D0 (en) | 1991-03-28 |
| YU184090A (en) | 1992-09-07 |
| IE903479A1 (en) | 1991-04-10 |
| ZA907579B (en) | 1991-06-26 |
| CZ277712B6 (en) | 1993-03-17 |
| CN1050503A (en) | 1991-04-10 |
| DE59002183D1 (en) | 1993-09-09 |
| EP0420049B1 (en) | 1993-08-04 |
| IS3631A7 (en) | 1991-03-29 |
| FI904756A0 (en) | 1990-09-27 |
| NZ235153A (en) | 1993-03-26 |
| HU205555B (en) | 1992-05-28 |
| AU6309890A (en) | 1991-04-11 |
| IL95769A0 (en) | 1991-06-30 |
| ATE92334T1 (en) | 1993-08-15 |
| NO904218L (en) | 1991-04-02 |
| HUT56284A (en) | 1991-08-28 |
| JPH03130232A (en) | 1991-06-04 |
| AR244551A1 (en) | 1993-11-30 |
| KR910005886A (en) | 1991-04-27 |
| MC2149A1 (en) | 1992-03-10 |
| FI904756A7 (en) | 1991-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0525610A3 (en) | Process for increasing the stability of enzymes and stabilized enzymes | |
| SG139553A1 (en) | 7-substituted-hept-6-enoic and -heptanoic acids and derivatives thereof | |
| AR242593A1 (en) | Procedure for the preparation of total or partial esters from hyaluronic acid. | |
| HU9202085D0 (en) | Derivatives of 7-isoindolinyl-quinolone and of naphthyridone-carboxylic acid | |
| AU588968B2 (en) | Pyrrolidineamide derivative of acylamino acid and pharmaceutical composition containing the same | |
| AU5829186A (en) | 2-thio or oxo-4-aryl or heterocyclo-1,5 (2h)- pyrimidinedi-carboxylic acid diesters and 3-acyl-5- pyrimidinecarboxylic acids and esters | |
| AU1114388A (en) | Anesthetic composition and method of using the same | |
| HU911185D0 (en) | Process for the production of liposomic medical preparations with peptide-contain and deferred effect | |
| AU6927087A (en) | 1,2,3,4-tetrahydro-6-substituted-4-aryl(or heterocyclo)-3- substituted-2-thioxo(or oxo)-5-pyrimidinecarboxylic acids and esters | |
| MY106615A (en) | Stabilized leukocyte-interferons. | |
| GR3003517T3 (en) | ||
| AU587077B2 (en) | Stabilization of iron in aqueous systems | |
| EP0313517A3 (en) | Aliphatic esters of 1,3,2-oxazaphospholidines | |
| NZ218856A (en) | Aminoglycosides of 3,21-dihydroxy-14,21-epoxy-24-nor-cholanic acid and derivatives | |
| BG49522A1 (en) | Pharmaceutist composition accelarating the healing of mounds | |
| AU624079B2 (en) | Novel fluorinated derivatives of amino acids usable more particularly as surfactants or cosurfactants and preparations for biomedical use incorporating these derivatives | |
| EP0437026A3 (en) | Use of tandospirone in the treatment of depression | |
| ZA864297B (en) | 3-(substituted)propenylaminothiazolylcephalosporanic acids and esters thereof | |
| AU625234B2 (en) | Stabilization of glycosylized t-pa | |
| EP0661981A1 (en) | Use of hyaluronic acid and forms to prevent arterial restenosis. | |
| AU9034291A (en) | Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance | |
| AU1789788A (en) | Cyclopolyglycuronic acid composition and its use | |
| AU6527390A (en) | Pharmaceutical compositions for the treatment of ataxy and equilibrium problems | |
| EP0311045A3 (en) | Triglycerides having stability with lapse of time and method for stabilization thereof | |
| EP0203528A3 (en) | Cyclopentene derivatives and their use as odorants |